Savefor later Page saved! You can go back to this later in your Diabetes and Me Close

Diabetes Research Steering Group: Type 1 treatments and prevention

The Type 1 Treatments and Prevention group aims to further research into preventing and treating type 1 diabetes. This group will cover the manipulation of the immune system for the prevention and treatment of type 1 diabetes, alongside cell therapy and islet cell transplantation. 

The group will also cover therapeutic targets and the development and study of drug treatments and insulin therapy in people with type 1 diabetes. 

If you would like to share your views with the group on where research into prevention, targets and therapies for type 1 diabetes should be focused, please get in touch:


Chair: Professor Colin Dayan, Cardiff University

Professor Colin Dayan has a long established interest in the underlying biology of type 1 diabetes and is currently conducting early phase clinical trials in the development of type 1 diabetes immunotherapy. 

Who's involved?

Our Diabetes Research Steering Groups are bringing together researchers, healthcare professionals and people with diabetes to create a roadmap for new research.

  • Associate Professor Ramzi Ajjan, Deputy Chair; Associate Professor; Consultant in Diabetes and Endocrinology, University of Leeds
  • David Dupont, Lay member
  • Becki Millar, Lay member
  • Daniel Gibbon, Lay member
  • Dr James Cantley, Diabetes UK RD Lawrence Fellow, University of Dundee
  • Dr Ivy Cheung, Statistician, Swansea University
  • Dr Shareen Forbes, Reader in Endocrinology; Honorary Consultant Physician; Lead Diabetologist Islet Transplant Programme Scotland, University of Edinburgh
  • Elaine Hibbert-Jones, Dietitian, Royal Gwent Hospital, Newport, (Wales)
  • Dr Vinod Patel, Professorial Clinical Teaching Fellow; Consultant Physician in Diabetes & Endocrinology, University of Warwick
Brand Icons/Telephonecheck - FontAwesomeicons/tickicons/uk